Invisalign - ALGN Net earnings per one share for the last twelve months

Invisalign (ALGN) - corporate logo

Align Technology, Inc. (ALGN) is betting on internal development by selectively acquiring software developers. However, declining disposable income and patent expirations create risks. The annual TTM net income per share dynamics confirm these fluctuations, where 33.10 becomes the new value of the indicator. Nevertheless, a colossal array of 3D data and AI provide the company with a technological superiority that remains unattainable for others.

ALGN: aligntech.com Net earnings per share for the last 12 months 02/11/2024 - 11/15/2026

Invisalign - analytical breakdowns and key metrics (ALGN)

- stock quotes and analyst forecast:
Quote Chart Align Technology|ALGN - Analyst Consensus Forecast
- issuer market value details:
Market Value Align Technology Inc|ALGN - Enterprise Value
- company book value details:
Equity per Share Align Technology|ALGN - Company Net Assets|Market Value to Book Value aligntech.com|ALGN - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Align Technology, Inc.|ALGN - Long-Term Debt to Capital|Current Liabilities to Capital Align Technology, Inc.|ALGN - Company Aggregate Debts|Debt to Book Value Ratio Align Technology Inc|ALGN - Company Long-Term Debts|Short-Term Debt Volume Align Technology|Quick Liquidity Indicator aligntech.com
- earnings and valuation multiples information:
ALGN - Net Profit|Projected Future Earnings Align Technology, Inc.|ALGN - Price to Earnings Ratio|Future Price to Earnings Align Technology, Inc.|ALGN - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Align Technology Inc|ALGN - Operating profit EBITDA|Net earnings per one share for the last twelve months Align Technology|ALGN - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year aligntech.com|ALGN - Net earnings per share growth this year|Earnings growth forecast for next year Align Technology, Inc.
- sales volume and revenue information:
ALGN - Revenue and Sales Volume|Company Future Sales Invisalign|ALGN - Price-to-Revenue Ratio|Future Price to Revenue Align Corp
Fundamental company valuation:Align Technology, ALGN
Manufactured product of Align Technology

The EPS TTM YoY trend measures the rate of change in net income per share over a rolling year, reflecting the actual efficiency of the business's capitalization. For Align Technology, Inc. (ALGN), this indicator captures the success of innovation implementation amid stable demand for medical services. By analyzing the 12-month YoY EPS growth chart, an investor can see the independence of earnings from economic cycles. The positive trend confirms the capital's resilience to market volatility.

Competitor analysis for Align Technology, Inc.

Net earnings per one share for the last twelve months Boston Scientific Corporation|EW (Edwards Lifesciences Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months RMD|PODD (Insulet) - Net earnings per share (EPS TTM)|ZBH: Earnings per share for the trailing year|Earnings per share for the last twelve months The Cooper Companies, Inc. (COO)|GMED (Globus Medical Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group TMDX|ATEC - Net earnings per share for the last 12 months|CryoLife - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Corporation|IART: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months ESTA|BBNX (iLet Bionic Pancreas) - Net earnings per share (EPS TTM)|Iradimed (IRMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) EMBC|Net earnings per share for the last 12 months Tandem Diabetes Care TNDM|Net earnings per share (EPS TTM) AXGN (axogeninc.com)|Net earnings per share (EPS TTM) SI-BONE Inc SIBN|OFIX - Earnings per share for the last twelve months|Earnings per share for the trailing year BVS (Bioventus Corp)|KIDS (OrthoPediatrics Inc.) - Net earnings per share for the last 12 months|Treace Medical Concepts - Earnings per share for the trailing year|SRTA (Strata Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Carlsmed, Inc. CARL|Earnings per share for the last twelve months RxSight Inc (RXST)|ClearPoint (CLPT) - Net earnings per share for the trailing year|Stereotaxis Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Neuronetics, Inc. STIM|Sight Sciences Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters orchestrabiomed.com OBIO|Anika Therapeutics, Inc. (ANIK) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months NSPR (InspireMD Inc.)|Earnings per share for the last twelve months zhjmedical.com|Net earnings per share for the last 12 months Vivani Medical, Inc. (VANI)|Net earnings per share (EPS TTM) XTNT|NMTC - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months modular-medical.com MODD|Earnings per share for the last four quarters MYO (Myomo Inc)|COCH: Net earnings per share for the last 12 months|Vivos Therapeutics, Inc. - Earnings per share for the last four quarters|NVNO: Net earnings per share (EPS TTM)|SINT - Net earnings per share for the last four quarters|TNON (tenonmed.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ReWalk Robotics Ltd. LFWD|Net earnings per share for the last 12 months AMIX (Autonomix Medical, Inc.)|IVF - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BBLG (Bone Biologics Inc)|AXNX: Earnings per share for the last 12 months|BIOLASE Inc. - Net earnings per share (EPS TTM)|Dynatronics - Earnings per share for the last four quarters|Paragon 28, Inc. (FNA) - Earnings per share for the last twelve months|INVO (INVO Bioscience Inc.) - Earnings per share for the last twelve months